Showing 4801-4810 of 7244 results for "".
- Arcutis Seeks FDA Greenlight to Expand ZORYVE for Children Under 6https://practicaldermatology.com/news/arcutis-seeks-fda-greenlight-to-expand-zoryve-for-children-under-6/2483230/Arcutis Biotherapeutics has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to expand the indication of ZORYVE® (roflumilast) cream 0.3% for the treatment of plaque psoriasis in children aged 2 to 5, according to
- Bimekizumab Achieves Dual Clearance of Nail and Skin Psoriasishttps://practicaldermatology.com/news/bimekizumab-achieves-dual-clearance-of-nail-and-skin-psoriasis/2483170/In pooled analyses of phase III and IIIb trials, bimekizumab was associated with significantly higher rates of complete clearance of both skin and nail psoriasis compared to adalimumab, ustekinumab, and secukinumab in patients with moderate-to-severe plaque psorias
- Recall of DermaRite Industries Products Expandshttps://practicaldermatology.com/news/recall-of-dermarite-sanitizers-and-cleansers-expands/2483166/Citing an abundance of caution, DermaRite Industries has announced it is expanding its voluntary recall of hand sanitizers and cleansers initiated on
- Amarte Relaunches Dermatologist-Formulated Ultra Veil Daily SPF 40https://practicaldermatology.com/news/amarte-relaunches-ultra-veil-daily-spf-40/2483087/Amarte Skin Care has relaunched its flagship sunscreen, ULTRA VEIL® DAILY SPF 40, according to a press release from the manufacturer. The updated product maintains its position as a top-tier hybrid sunscreen, the press release
- Deucravacitinib Shows Sustained Efficacy in Plaque Psoriasis Through 3 Years: Studyhttps://practicaldermatology.com/news/deucravacitinib-shows-sustained-efficacy-in-plaque-psoriasis-through-3-years-study/2483055/Deucravacitinib, a first-in-class oral selective TYK2 inhibitor, has demonstrated durable efficacy and a favorable safety profile in patients with moderate-to-severe plaque psoriasis, according to a recent review of phase III and long-term data.
- ASDSA Pushes for Stronger Sun Protection Through SUNucate Legislationhttps://practicaldermatology.com/news/asdsa-pushes-for-stronger-sun-protection-through-sunucate-legislation/2482983/The American Society for Dermatologic Surgery Association (ASDSA) has updated its SUNucate model legislation to expand its reach beyond sunscreen use in schools and school-sponsored events, according to a news release. The SUN
- New Agreement Opens Premier Networks to TeleVox Techhttps://practicaldermatology.com/news/televox-and-premier-inc-announce-national-patient-engagement-agreement/2476115/TeleVox has announced a national group purchasing agreement with Premier, Inc. effective September 1, 2025, permiting Premier members to access negotiated pricing and terms for TeleVox offerings, including Digital Front Door, Appointment Management, Digital Care P
- DermaRite Recalls Four Skin Care Products Over Burkholderia cepacia Contamination Riskhttps://practicaldermatology.com/news/dermarite-recalls-four-skin-care-products-over-burkholderia-cepacia-contamination-risk/2476092/DermaRite Industries has issued a nationwide recall of four over-the-counter antiseptic and analgesic products after tests detected contamination with Burkholderia cepacia complex (BCC), according to a statement released by
- Study: Ustekinumab Shows Durability in Real-World Psoriasis Biologic Sequencing Studyhttps://practicaldermatology.com/news/study-ustekinumab-shows-durability-in-real-world-psoriasis-biologic-sequencing-study/2476000/Ustekinumab (Stelara) was associated with the longest treatment duration among biologics used for moderate-to-severe psoriasis, according to results from a recent retrospective real-world analysis. Researchers evaluated health
- Rejuva Fresh Launches Upgraded Custom CORE™ 8D Multi-Platform Laserhttps://practicaldermatology.com/news/rejuva-fresh-launches-upgraded-custom-coretm-8d-multi-platform-laser/2475979/Rejuva Fresh has announced the release of its updated Custom CORE™ 8D Multi-Platform Laser, according to a press release from the manufacturer.